First vaccine to protect adults from Chikungunya
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
First vaccine to protect adults from Chikungunya
Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Scientific guideline
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products - Scientific guideline
Summary of opinion: Kinpeygo, 30/05/2024 Positive
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
Summary of opinion: Kinpeygo, 30/05/2024 Positive
Summary of opinion: Livmarli, 30/05/2024 Positive
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
Summary of opinion: Livmarli, 30/05/2024 Positive
Summary of opinion: Eliquis, 30/05/2024 Positive
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
Summary of opinion: Eliquis, 30/05/2024 Positive
Summary of opinion: Skyrizi, 30/05/2024 Positive
Submitted by Anonymous (not verified) on 31 May 2024 - 11:00
Summary of opinion: Skyrizi, 30/05/2024 Positive
New gene therapy treatment for haemophilia B
Submitted by Anonymous (not verified) on 31 May 2024 - 10:48
New gene therapy treatment for haemophilia B
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa
Submitted by Anonymous (not verified) on 31 May 2024 - 8:12
Questions and answers relating to Grant Procedure no. EMA/GRANT/2024/02/IA - Medicines regulatory systems strengthening in Sub-Saharan Africa
Frequently asked questions about parallel distribution
Submitted by Anonymous (not verified) on 31 May 2024 - 8:08
Frequently asked questions about parallel distribution
Checklist for annual updates for parallel distribution: guidance for industry
Submitted by Anonymous (not verified) on 31 May 2024 - 8:08
Checklist for annual updates for parallel distribution: guidance for industry